‘Skinny Label’ Litigation: Generic Firms Rethinking Strategy, May Pursue Legislation

 
• By Brenda Sandburg
Skinny label
Litigation over generic drug skinny labels will remain a trendy topic in 2022. • Source: Alamy

More from Pink Sheet Perspectives

More from Pink Sheet